Table 1.
Summary of controlled trials examining the need for concomitant immunosuppression in patients with Crohn's disease receiving scheduled maintenance therapy with infliximab.

Summary of controlled trials examining the need for concomitant immunosuppression in patients with Crohn's disease receiving scheduled maintenance therapy with infliximab.
